39
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019

      research-article
      1 , 2 , 3
      (Collab)
      Chinese Medical Journal
      Wolters Kluwer Health

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction Since December 2019, the coronavirus disease 2019 (COVID-19) has become a public health emergency. COVID-19 has already been classified as a category B infectious disease according to the Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, and control measures for category A infectious diseases have been adopted. The National Health Commission has also published diagnosis and treatment protocols to guide the clinical diagnosis and treatment. With the accumulating experience of treating COVID-19 patients, particularly severely and critically ill patients, in clinical practice, our understanding of COVID-19 has continuously deepened. With regard to varying degrees of respiratory, physical, and psychological dysfunction in patients,[1] it is vital to standardize respiratory rehabilitation techniques and procedures for respiratory rehabilitation in various regions. Hence, we combined the opinions of frontline epidemic control experts and reviewed the evidence in relevant literature. Based on the “Coronavirus Disease 2019 Respiratory Rehabilitation Guidelines (First Edition),”[2] we organized experts in evidence-based medicine, respiratory and critical care medicine, and rehabilitation medicine in China, and invited some experts at the frontline of epidemic control in Wuhan and other cities in Hubei province to jointly draft these recommendations. Methodology Registration These recommendations were registered at the International Practice Guidelines Registry Platform (http://www.guidelines-registry.org; registration number: IPGRP-2020CN016). Recommendation work group The recommendation work group was divided into the recommendation drafting group, evidence assessment group, and expert consensus group. The drafting group is responsible for determining the topic and scope of the recommendations, guiding the evidence assessment group in evidence summary, and drafting recommendations. The evidence assessment group is responsible for searching, assessing, and providing a summary of relevant evidence. The expert consensus group is responsible for achieving a consensus from the preliminary recommendations. Literature search Our recommendations included rehabilitation-related guidelines, systemic reviews, and randomized controlled trials with regard to three infectious diseases (COVID-19, severe acute respiratory syndrome [SARS], and Middle East respiratory syndrome [MERS]). Two members of the evidence assessment team performed independent computer searches of English databases (PubMed, Ovid, Embase), Chinese databases (Chinese Biological Medical Literature database, China National Knowledge Infrastructure, Chinese Medical Journal Database), and relevant online website bulletins on COVID-19 (the World Health Organization, Elsevier, the Lancet, the New England Journal of Medicine, and the Journal of the American Medical Association, 2019 Novel Coronavirus Resource (2019nCoVR), and the Chinese Medical Journal Network). The search period was from database construction to February 21, 2020. The search terms included the English terms and their Chinese equivalents: “novel coronavirus pneumonia,” “NCP,” “severe acute respiratory syndrome,” “SARS,” “Middle East Respiratory Syndrome,” “MERS,” “influenza,” “psychological therapy,” “guideline,” “statement,” “recommendation,” “randomized controlled trial,” and other rehabilitation-related English search terms and their Chinese equivalents included “respiratory rehabilitation,” “pulmonary rehabilitation,” “physiotherapy,” “physical therapy,” and “occupational therapy.” If the complete article was unavailable, we emailed the corresponding author to obtain it. Paper screening and evidence summary Two members of the evidence assessment group used the Endnote X9 literature management software to screen the literature independently according to the inclusion and exclusion criteria. Different rehabilitation topics were used for classification and to summarize the results of the included articles. Cross-verification was carried out by two staff members during screening and during the preparation of the summary. If there was any dispute, a third researcher intervened, discussed, and resolved the dispute. Quality assessment The evidence assessment group employed the Appraisal of Guidelines for Research & Evaluation II tool for methodological quality assessment of the included guidelines, the Assessment of Multiple Systematic Reviews tool for quality assessment of systematic reviews, and the Cochrane bias risk assessment tool for bias risk assessment of randomized controlled trials. Generation of recommendations and consensus Based on the evidence summary and quality assessment results, the recommendation drafting group combined all existing recommendations and drafted a preliminary version of rehabilitation recommendations. The recommendations were submitted to the expert consensus group, and a consensus was reached through panel discussions, which was then determined to be the final draft of the recommendations. Basic Principles of Respiratory Rehabilitation Prerequisite First, the requirements of the “Guidelines for COVID-19 Prevention and Control in Medical Institutions (1st Edition)”[3] printed by the National Health Commission should be strictly complied with. All staffs who had a close contact with patients for respiratory rehabilitation assessment and treatment must pass the infection control training and examination in the local hospital before they can start to work. Aim For COVID-19 inpatients, the aim of respiratory rehabilitation is to ameliorate dyspnea, alleviate anxiety and depression, reduce complications, prevent and improve dysfunction, reduce morbidity, preserve functions, and improve quality of life as much as possible. Timing Early respiratory rehabilitation is not recommended for severely and critically ill patients if their condition remains unstabilized or progressively deteriorates. The timing of respiratory rehabilitation intervention should exclude contraindications for respiratory rehabilitation and should not aggravate the burdens of infection prevention. The staged respiratory rehabilitation measures can be employed at the later stages for discharged patients with different sequelae. Methods For patients in isolation ward, educational videos, self-management booklet, and remote consultation are recommended during respiratory rehabilitation to reduce the usage of protective equipment and avoid cross-infection. Integrated rehabilitation using multiple methods can be employed in patients who meet the recovery criteria and are no longer under quarantine observation based on their indications and conditions. Personalization The principle of personalization must be adhered to regardless of the type of respiratory rehabilitation intervention. In particular, for patients with severe/critical condition, older adults, obesity patients, patients with multiple comorbidities, and patients with one or more organ failure, the respiratory rehabilitation team should customize a respiratory rehabilitation plan based on the unique problems of each patient. Evaluation Evaluation and monitoring must be conducted from the initiation until the completion of respiratory rehabilitation. Protection [Table 1] The staff must refer to the requirements indicated in the “Recommendations for Airway Management in Adult Severe Coronavirus Disease 2019 Patients (Interim)” and determine the appropriate protective measures according to the type of task.[4] Table 1 Protection categories when performing respiratory rehabilitation for COVID-19 patients. Respiratory Rehabilitation Recommendations for Mildly ill Patients During Hospitalization (Only for Cabin Hospitals) The clinical symptoms of the patient are mild and may include fever, fatigue, coughing, and one or more physical dysfunctions.[5,6] During quarantine, patients with confirmed disease may show anger, fear, anxiety, depression, insomnia or aggression, and loneliness, or will be uncooperative due to fear of the disease. The patients will tend to give up treatment or develop other psychological problems.[7] Respiratory rehabilitation can ameliorate anxiety and depression in patients.[8] Recommendations Patient education (1) Advocacy, videos, and booklet are used to help patients understand the disease and treatment process; (2) the patients are required to take regular rest and have sufficient sleep; (3) they are encouraged to eat a balanced diet; (4) they are advised to stop smoking. Activity recommendations (1) Exercise intensity: Borg dyspnea score ≤3 points (total score: 10 points), fatigue should be absent on Day 2 preferably; (2) Exercise frequency: twice a day, duration 15 to 45 min/session, 1 h after meals; and (3) type of exercise: breathing exercise, Tai chi, or square dancing. Psychological intervention (1) Self-assessment scales are used to rapidly identify the type of psychological dysfunction. (2) If necessary, the patients should visit the psychologists or ask for help through mental health hotline. Respiratory Rehabilitation Recommendations for Moderately ill Patients During Hospitalization (Only for Cabin Hospitals) Isolation is an effective method for reducing the transmission of disease. However, isolation causes patients to have limited exercise space. In addition, patients experience fever, fatigue, muscle ache, and so on,[6] and the duration of sitting and lying down is significantly increased for most patients. Prolong bed rest will decrease muscle strength, result in poor expulsion of sputum,[9] and significantly increase the risk of deep vein thrombosis.[10] Moreover, anxiety, depression, and fatigue will result in exercise intolerance.[11] Recommendations Intervention timing for respiratory rehabilitation in moderately ill patients Due to the limited understanding of the pathophysiological mechanisms of COVID-19, current clinical observations found that around 3% to 5% of moderately ill patients develop severe or even critical disease after 7 to 14 days of infection. Therefore, the exercise intensity should not be too high as its objective is to maintain the existing physical status. After the patient is admitted to the cabin hospital, data on the patient's initial consultation time, duration from disease onset to dyspnea, and blood oxygen saturation (SpO2)[12,13] should be assessed to determine if the respiratory rehabilitation can be initiated. Exclusion criteria Patients (1) with a temperature >38.0°C, (2) with an initial consultation time ≤7 days, (3) in whom the duration from disease onset to dyspnea is ≤3 days, (4) whose chest radiological scans show >50% progression within 24 to 48 h, (5) with an SpO2 level of ≤95%, and (6) with a resting blood pressure of <90/60 (1 mmHg = 0.133 kPa) or >140/90 mmHg. Exercise termination criteria Respiratory rehabilitation is immediately discontinued when one of the following conditions develops during rehabilitation: (1) dyspnea index: Borg dyspnea score >3 (total score: 10 points); (2) chest tightness, shortness of breath, dizziness, headache, blurred vision, heart palpitations, profuse sweating, and balance disorder; and (3) other conditions that the clinician determines to be unsuitable for exercise. Assistance should be sought from physicians and nurses. Primary intervention measures for respiratory rehabilitation include airway clearance, breathing control, physical activity, and exercise (1) Airway clearance: (i) dilation during deep breathing exercise can be used to help sputum expectoration and (ii) a sealed plastic bag should be used when coughing to avoid virus transmission. (2) Breathing control: (i) positioning: An upright sitting position is usually adopted. Patients with shortness of breath should adopt a semi-sitting position or a leaning forward position; (ii) maneuvers: During training, the accessory muscles of the shoulders and neck are relaxed, and the patient slowly inhales through the nose and slowly exhales through the mouth. Attention is paid to the expansion of the lower chest. (3) Physical activity and exercise recommendations: (i) intensity: The recommended exercise intensity is between rest (1.0 metabolic equivalents [METs]) and light exercise (<3.0 METs); (ii) frequency: Exercise is performed twice a day, 1 h after meal; (iii) duration: The exercise duration is based on the patient's physical status, and each session lasts 15 to 45 min. Patients who are prone to fatigue or are physically weak should perform intermittent exercise; (iv) type of exercise: breathing exercises, stepping, Tai chi, and exercises that are recommended to prevent thrombosis; and (v) the management of patients with limited locomotor activity is the same as that for severely ill patients. Respiratory Rehabilitation Treatment for Severely and Critically Ill Patients Severely and critically ill patients account for 15.7% of the number of confirmed cases.[6] The latest pathology results show that early-[14] and late-stage pulmonary lesions are mainly due to diffuse alveolar injury, significant fibrosis did not occur, and diffuse lymphocyte infiltration is present between myocardial fibers, and the possibility of comorbid viral myocarditis cannot be excluded.[15] Many COVID-19 patients who are given mechanical ventilation under deep sedation and receiving analgesia completely lose spontaneous breathing and have no or weak response to stimuli, and the incidence of delirium in patients is high.[16] Respiratory rehabilitation can be initiated at a suitable time and can significantly reduce delirium and mechanical ventilation duration, and eventually improve the patient's functional status.[17] Before performing the rehabilitation intervention in severely and critically ill patients, a comprehensive evaluation of the patient's systemic function is required, particularly in terms of cognitive status, respiratory function, cardiovascular function, and musculoskeletal function. Treatment should be initiated as soon as possible in patients who are eligible for respiratory rehabilitation. Before initiating treatment, a consensus from the medical team must be obtained, and sufficient preparations should be made. Reassessment should be carried out in patients who do not fulfill the criteria for respiratory rehabilitation, and respiratory rehabilitation can only be performed once they satisfy the criteria. If adverse events occur during rehabilitation, rehabilitation should be discontinued immediately, and the chief physician must be informed. The cause should be determined, and safety should be re-evaluated. Due to safety and human resource concerns, only the recommended bed and bedside activities are carried out during rehabilitation in severely and critically ill patients. Rehabilitation intervention measures must cover three major areas: (1) positioning management, (2) early mobilization, and (3) respiratory management. The therapeutic interventions should be based on the patient's cognitive status and functional status. Recommendations Timing of intervention Respiratory rehabilitation can be initiated once all of the following criteria are met[18]: (1) respiratory system: (i) fraction of inspired oxygen ≤0.6, (ii) SpO2 ≥90%, (iii) respiratory rate ≤40 breaths/min (bpm), (iv) positive end expiratory pressure ≤10 cmH2O (1 cmH2O = 0.098 kPa), (v) absence of ventilator resistance, and (vi) absence of unsafe hidden airway problems; (2) cardiovascular system: (i) systolic blood pressure ≥90 and ≤180 mmHg, (ii) mean arterial pressure (MAP) ≥65 and ≤110 mmHg, (iii) heart rate ≥40 and ≤120 beats/min, (iv) absence of new arrhythmia or myocardial ischemia, (v) absence of shock with lactic acid level ≥4 mmol/L, (vi) absence of new unstable deep vein thrombosis and pulmonary embolism, and (vii) absence of suspected aortic stenosis; (3) nervous system: (i) Richmond Agitation-Sedation Scale score: −2 to +2 and (ii) intracranial pressure <20 cmH2O; and (4) others: (i) absence of unstable limb and spinal fractures, (ii) absence of severe underlying hepatic/renal disease or new progressively worsening hepatic/renal impairment, (iii) absence of active hemorrhage, and (iv) temperature ≤38.5°C. Early rehabilitation is discontinued immediately if the following conditions occur [18] (1) Respiratory system: (i) SpO2 <90% or decrease by >4% from baseline, (ii) respiratory rate >40 bpm, (iii) ventilator resistance, and (iv) artificial airway dislodgement or migration; (2) cardiovascular system: (i) systolic blood pressure <90 or >180 mmHg, (ii) MAP <65 or >110 mmHg, or >20% change compared with baseline, (iii) heart rate <40 or >120 beats/min, and (iv) new arrhythmia and myocardial ischemia; (3) nervous system: (i) loss of consciousness and (ii) irritability; and (4) others: (i) discontinuation of any treatment or removal of monitoring tube connected to the patient; (ii) patient-perceived heart palpitations, exacerbation of dyspnea or shortness of breath, and intolerable fatigue; and (iii) falls in patient. Respiratory rehabilitation intervention measures (1) Positioning management: In case that physiological status permits, anti-gravity posture simulation is gradually increased until the patient can maintain an upright position, such as raising the head of the bed by 60°; the lower edge of the pillow is placed on one-third of the scapula to prevent head hyperextension. A pillow is placed below the popliteal fossa to relax the lower limbs and abdomen. Positioning management is carried out in 30-min sessions and three sessions are conducted each day.[19] Prone position ventilation is carried out in acute respiratory distress syndrome (ARDS) patients for 12 h and above.[20] (2) Early mobilization: Attention should be paid during the entire activity to prevent tubing detachment, and vital signs should be monitored during the entire process. (i) Intensity: Lower strength, duration, or activity scope can be used in patients with poor physical status, and patients only need to complete the movements; (ii) duration: The total training duration for a single session should not exceed 30 min nor exacerbate fatigue; (iii) type of exercise: First, regular turnover and movement on the bed, sitting up on bed, moving from the bed to chair, sitting on the chair, standing up, and stepping should be carried out step by step. Second, active/passive exercise training is performed within the full range of motion (ROM).[21] Third, for patients receiving sedatives or patients with loss of consciousness, cognitive dysfunction, or with limited physiological conditions, treatments include bedside lower limb passive exercise bicycle, passive joint movement and stretch exercise, and neuromuscular electrical stimulation.[22] (3) Respiratory management: This mainly includes lung recruitment and sputum expulsion and does not require therapist to have long periods of patient contact. The management should not trigger severe cough and increase the work of breathing. High-frequency chest wall oscillation,[23] and oscillatory positive expiratory pressure (OPEP) are among the recommended treatment methods.[24] Respiratory Rehabilitation Treatment for Discharged Patients Mildly and moderately ill patients after discharge Post-discharge rehabilitation of mildly and moderately ill patients mainly consists of improving physical fitness and psychological adjustment. Progressive aerobic exercises can be selected so that patients can gradually recover the level of activity before disease onset and eventually return to society. Severely/critically ill patients after discharge Severely/critically ill COVID-19 patients with respiratory and/or limb dysfunction after discharge should undergo respiratory rehabilitation. Based on the findings in discharged SARS and MERS patients[25,26] and clinical experience on post-discharge rehabilitation in ARDS patients, COVID-19 patients may have poor physical fitness, post-exertion shortness of breath, muscle atrophy (including respiratory muscles and trunk and limb muscles),[27] and post-traumatic stress disorder.[28] The specialist should be consulted on precautions if the patients have comorbidities such as pulmonary hypertension, myocarditis, congestive heart failure, deep vein thrombosis, and unstable fracture before commencing respiratory rehabilitation treatment. Recommendations Exclusion criteria (1) A heart rate of >100 beats/min, (2) a blood pressure of <90/60 or >140/90 mmHg, (3) an SpO2 of ≤95%, and (4) other diseases that are not suitable for exercise. Exercise termination criteria Patients who experience (1) temperature fluctuation (>37.2°C), (2) exacerbation of respiratory symptoms and fatigue that are not alleviated after rest should discontinue exercises immediately. The physician should be consulted if the following symptoms occur: chest tightness, chest pain, dyspnea, severe cough, dizziness, headache, blurred vision, heart palpitations, profuse sweating, and unstable gait. Rehabilitation evaluation (1) Clinical evaluation: physical examination, imaging tests, laboratory tests, lung function test, nutrition screening, and ultrasonography. (2) Exercise and respiratory function evaluation: (i) respiratory muscle strength: maximum inspiratory pressure/maximum expiratory pressure; (ii) muscle strength: the UK Medical Research Council test, manual muscle test, and isokinetic muscle testing; (iii) joint ROM test; (iv) balance function evaluation: Berg balance scale; (v) aerobic exercise capacity: 6-min walk test and cardiopulmonary exercise testing; and (vi) physical activity evaluation: International Physical Activity Questionnaire and Physical Activity Scale for the Elderly. (3) Evaluation of activities of daily living (ADL): The Barthel index is used to evaluate ADLs. Respiratory rehabilitation intervention (1) Patient education: (i) booklet and videos should be made to explain the importance, specifics, and precautions of respiratory rehabilitation to increase patient compliance; (ii) healthy lifestyle education; (iii) encouraging patients to participate in family and social activities. (2) Respiratory rehabilitation recommendations: (i) aerobic exercises: aerobic exercises are customized according to the patient's underlying disease and residual dysfunction. These exercises include walking, brisk walking, slow jogging, and swimming, and begin at a low intensity before progressively increasing in intensity and duration. A total of 3 to 5 sessions are carried out per week, and each session lasts 20 to 30 min. Patients who are prone to fatigue should perform intermittent exercises. (ii) Strength training: progressive resistance training[25,29] is recommended for strength training. The training load for each target muscle group is 8 to 12 repetitions maximum; that is, each group will repeat 8 to 12 movements, 1 to 3 sets/time, with 2-min rest intervals between sets, with a frequency of 2 to 3 sessions/week for 6 weeks. Approximately 5% to 10% is increased per week; (iii) balance training: balance training should be carried out in patients with comorbid balance disorders, including hands-free balance training under the guidance of the rehabilitation therapist and using balance trainer; (iv) breathing exercise: if shortness of breath, wheezing, and difficulty in expelling sputum occur in patients after discharge, the evaluation results should be used to arrange the intentional breathing exercise[30,31] and airway clearance techniques.[32] Breathing exercise: this includes posture management, adjustment of breathing rhythm, thoracic expansion training, mobilization of respiratory muscle groups, and so on. Airway clearance techniques: first, forced expiratory techniques can be used at the early stages of airway clearance after discharge in patients with chronic airway disease to expel sputum and reduce coughing and energy consumption; second, positive expiratory pressure/OPEP can be used as aids. (3) ADL guidance: (i) basic ADLs: the patient's ability in transferring, getting dressed, toileting, and bathing are assessed, and rehabilitation guidance is provided for these activities[33]; (ii) instrumental ADLs (IADLs): the IADL of the patient is assessed to identify any disorders in tasks. Targeted intervention is carried out under the guidance of the occupational therapist. Traditional Chinese Medicine Respiratory Rehabilitation Traditional Chinese medicine respiratory rehabilitation is mainly targeted to mildly, moderately ill, and discharged patients. If there is no contraindication (limb disorder, altered consciousness, etc), Baduanjin qigong,[34–36] 24-form tai chi chuan,[34–38] guided breathing exercise training,[8,39] or six-character mnemonic[34,37] can be carried out after assessment by specialists. One or two of these exercises can be used. The recommendations are as follows: Baduanjin qigong During practice, the movements should be relaxed, natural, correct, and flexible; should combine both training and support; and should be progressive. All eight moves are performed 6 to 8 times, with a total duration of 30 min. One set is performed per day. Twenty-four-form tai chi chuan Gentle movements, with emphasis on conscious breathing in coordination with systemic movements. Each set (which includes pre-training preparatory exercises and relaxation exercises after completion) requires 50 min. One set is carried out per day (https://mp.weixin.qq.com/s/NYY5Ts4N09zzZCpiL8nAvg). Guided breathing exercises This includes six sections: standing in relaxed and tranquil pose, breathing in qi to Dantian, recuperating the lung and kidney, twisting the body and moving the hands, kneading the Shenshu point, and drawing in exercises with cultivating qi. Each set requires around 30 min. One set is carried out per day (https://mp.weixin.qq.com/s/1eNdxRWRoPKoxgIvZ9xpQw). Qigong rehabilitation method The six-character mnemonic uses different sounds (xi, he, hu, xu, chui, and xi) to regulate qi and blood flow through the organs and meridians. Every character is recited six times for each set. Each set requires around 30 min. One set is performed per day (https://mp.weixin.qq.com/s/ibsxWq5cDo40Jxz8mZzv-Q). Conclusions Combining the latest research results and accumulated clinical experience on respiratory rehabilitation and COVID-19 from China and other countries, we cautiously added the timing for respiratory rehabilitation and revised the respiratory rehabilitation protocol targeted at clinical problems at different stages based on the first edition. We hope that this can aid in frontline clinical diagnosis and treatment to maintain the physical function of patients while simultaneously promoting psychological reconstruction and capacity for remodeling activity. With our deepening understanding of COVID-19 and the increase in the number of cured and discharged patients, the updated third edition will provide more detailed guidelines for home respiratory rehabilitation. Finally, we would like to express our respect to all frontline staff against COVID-19 epidemic. Main reviewing expert Chinese Academy of Medical Sciences and Peking Union Medical College (Chen Wang) and Chinese Association of Rehabilitation Medicine (Guo-En Fang) Drafting experts Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Diseases (Hong-Mei Zhao, Qing Zhao), Department of Rehabilitation Medicine, China-Japan Friendship Hospital (Yu-Xiao Xie, Ya-Jing Duan, Si-Yuan Wang, and Xuan-Ming Situ); Rehabilitation Medical Center, West China Hospital, Sichuan University (Peng-Ming Yu); Department of Rehabilitation Medicine, Fourth Medical Center of People's Liberation Army General Hospital (Shan Jiang); and Henan University of Traditional Chinese Medicine (Jian-Sheng Li). Discussion expert group Chinese Association of Rehabilitation Medicine (Guo-En Fang, En-Xi Niu, and Tie-Bin Yan); Chinese Academy of Medical Sciences and Peking Union Medical College, Center of Respiratory Medicine, China-Japan Friendship Hospital (Chen Wang); China-Japan Friendship Hospital (Jun Duan, Ya-Jing Duan, Peng Feng, Gang Li, Xuan-Ming Situ, Si-Yuan Wang, Yu-Xiao Xie, Ting Yang, Hong-Mei Zhao, and Qing Zhao); Peking University Third Hospital (Xiao-Bian Liu and Mou-Wang Zhou); Beijing Hospital (Fan Dong); Zhongshan Hospital Affiliated to Fudan University (Yuan-Lin Song); Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology (Xiao-Lin Huang and Jian-Ping Zhao); Henan University of Traditional Chinese Medicine (Jian-Sheng Li and Hai-Long Zhang); The 2nd Affiliated Hospital of Harbin Medical University (Hong Chen); The General Hospital of the People's Liberation Army (Li-Xin Xie); Fourth Medical Center of People's Liberation Army General Hospital (Shan Jiang); Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University/GRADE China Center (Yao-Long Chen); Xinqiao Hospital, Army Medical University (Qi Li); Binzhou People's Hospital, Shandong First Medical University (Meng-Meng Wu); West China Hospital, Sichuan University (Zong-An Liang, Peng-Ming Yu); Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine (Wei-Ning Xiong); Shanghai University of Medicine & Health Sciences (Qi Guo); First Affiliated Hospital of Xi’an Jiao Tong University (Zhi-Hong Shi); Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (Hui-Qing Ge); Xiangya Hospital, Central South University (Pin-Hua Pan); Third Affiliated Hospital of Sun Yat-Sen University (Hai-Qing Zheng); and Guang’anmen Hospital, China Academy of Chinese Medical Sciences (Guang-Xi Li). Evidence assessment group Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University/GRADE China Center (Yao-Long Chen and Nan Yang) and China-Japan Friendship Hospital (Xuan He, Qian Lu, Ming-Zhen Li, Xu-Yan Liu, Jia-Xi Wang, and Rui-Ze Xu). External review expert group Peking University First Hospital (Chun-Hua Chi and Ning-Hua Wang); Department of Rehabilitation Medicine, Beijing Hospital (Xin Gu); Hainan Branch of the General Hospital of the People's Liberation Army (Yu-Zhu Li); Second Hospital of Jilin University (Jie Zhang); Southwest Hospital, Army Medical University (Hong-Liang Liu), Inner Mongolia People's Hospital (De-Jun Sun); Qingdao Municipal Hospital (Group) (Wei Han and Hua-Ping Tang); Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (Qing Xie); Weifang No. 2 People's Hospital (Guo-Ru Yang); People's Hospital of Xinjiang Uyghur Autonomous Region (Xiao-Hong Yang); Chongqing Hospital, University of Chinese Academy of Sciences (Yong Huang); China-Japan Friendship Hospital (Hong-Chun Zhang and Jing Zhao); Xiangya Hospital, Central South University (Cheng-Ping Hu); and The Second Xiangya Hospital of Central South University (Shan Cai and Hong Luo). Frontline experts in the fight against COVID-19 in Wuhan Hong Chen, Fan Dong, Jun Duan, Hui-Qing Ge, Xiao-Lin Huang, Gang Li, Qi Li, Pin-Hua Pan, Yuan-Lin Song, Zhi-Hong Shi, Meng-Meng Wu, Wei-Ning Xiong, Jian-Ping Zhao, Hai-Qing Zheng. Conflicts of interest None.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

          Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. Interpretation The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Clinical Characteristics of Coronavirus Disease 2019 in China

            Abstract Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. Methods We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death. Results The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission. Conclusions During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Pathological findings of COVID-19 associated with acute respiratory distress syndrome

              Since late December, 2019, an outbreak of a novel coronavirus disease (COVID-19; previously known as 2019-nCoV)1, 2 was reported in Wuhan, China, 2 which has subsequently affected 26 countries worldwide. In general, COVID-19 is an acute resolved disease but it can also be deadly, with a 2% case fatality rate. Severe disease onset might result in death due to massive alveolar damage and progressive respiratory failure.2, 3 As of Feb 15, about 66 580 cases have been confirmed and over 1524 deaths. However, no pathology has been reported due to barely accessible autopsy or biopsy.2, 3 Here, we investigated the pathological characteristics of a patient who died from severe infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by postmortem biopsies. This study is in accordance with regulations issued by the National Health Commission of China and the Helsinki Declaration. Our findings will facilitate understanding of the pathogenesis of COVID-19 and improve clinical strategies against the disease. A 50-year-old man was admitted to a fever clinic on Jan 21, 2020, with symptoms of fever, chills, cough, fatigue and shortness of breath. He reported a travel history to Wuhan Jan 8–12, and that he had initial symptoms of mild chills and dry cough on Jan 14 (day 1 of illness) but did not see a doctor and kept working until Jan 21 (figure 1 ). Chest x-ray showed multiple patchy shadows in both lungs (appendix p 2), and a throat swab sample was taken. On Jan 22 (day 9 of illness), the Beijing Centers for Disease Control (CDC) confirmed by reverse real-time PCR assay that the patient had COVID-19. Figure 1 Timeline of disease course according to days from initial presentation of illness and days from hospital admission, from Jan 8–27, 2020 SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. He was immediately admitted to the isolation ward and received supplemental oxygen through a face mask. He was given interferon alfa-2b (5 million units twice daily, atomisation inhalation) and lopinavir plus ritonavir (500 mg twice daily, orally) as antiviral therapy, and moxifloxacin (0·4 g once daily, intravenously) to prevent secondary infection. Given the serious shortness of breath and hypoxaemia, methylprednisolone (80 mg twice daily, intravenously) was administered to attenuate lung inflammation. Laboratory tests results are listed in the appendix (p 4). After receiving medication, his body temperature reduced from 39·0 to 36·4 °C. However, his cough, dyspnoea, and fatigue did not improve. On day 12 of illness, after initial presentation, chest x-ray showed progressive infiltrate and diffuse gridding shadow in both lungs. He refused ventilator support in the intensive care unit repeatedly because he suffered from claustrophobia; therefore, he received high-flow nasal cannula (HFNC) oxygen therapy (60% concentration, flow rate 40 L/min). On day 13 of illness, the patient's symptoms had still not improved, but oxygen saturation remained above 95%. In the afternoon of day 14 of illness, his hypoxaemia and shortness of breath worsened. Despite receiving HFNC oxygen therapy (100% concentration, flow rate 40 L/min), oxygen saturation values decreased to 60%, and the patient had sudden cardiac arrest. He was immediately given invasive ventilation, chest compression, and adrenaline injection. Unfortunately, the rescue was not successful, and he died at 18:31 (Beijing time). Biopsy samples were taken from lung, liver, and heart tissue of the patient. Histological examination showed bilateral diffuse alveolar damage with cellular fibromyxoid exudates (figure 2A, B ). The right lung showed evident desquamation of pneumocytes and hyaline membrane formation, indicating acute respiratory distress syndrome (ARDS; figure 2A). The left lung tissue displayed pulmonary oedema with hyaline membrane formation, suggestive of early-phase ARDS (figure 2B). Interstitial mononuclear inflammatory infiltrates, dominated by lymphocytes, were seen in both lungs. Multinucleated syncytial cells with atypical enlarged pneumocytes characterised by large nuclei, amphophilic granular cytoplasm, and prominent nucleoli were identified in the intra-alveolar spaces, showing viral cytopathic-like changes. No obvious intranuclear or intracytoplasmic viral inclusions were identified. Figure 2 Pathological manifestations of right (A) and left (B) lung tissue, liver tissue (C), and heart tissue (D) in a patient with severe pneumonia caused by SARS-CoV-2 SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. The pathological features of COVID-19 greatly resemble those seen in SARS and Middle Eastern respiratory syndrome (MERS) coronavirus infection.4, 5 In addition, the liver biopsy specimens of the patient with COVID-19 showed moderate microvesicular steatosis and mild lobular and portal activity (figure 2C), indicating the injury could have been caused by either SARS-CoV-2 infection or drug-induced liver injury. There were a few interstitial mononuclear inflammatory infiltrates, but no other substantial damage in the heart tissue (figure 2D). Peripheral blood was prepared for flow cytometric analysis. We found that the counts of peripheral CD4 and CD8 T cells were substantially reduced, while their status was hyperactivated, as evidenced by the high proportions of HLA-DR (CD4 3·47%) and CD38 (CD8 39·4%) double-positive fractions (appendix p 3). Moreover, there was an increased concentration of highly proinflammatory CCR6+ Th17 in CD4 T cells (appendix p 3). Additionally, CD8 T cells were found to harbour high concentrations of cytotoxic granules, in which 31·6% cells were perforin positive, 64·2% cells were granulysin positive, and 30·5% cells were granulysin and perforin double-positive (appendix p 3). Our results imply that overactivation of T cells, manifested by increase of Th17 and high cytotoxicity of CD8 T cells, accounts for, in part, the severe immune injury in this patient. X-ray images showed rapid progression of pneumonia and some differences between the left and right lung. In addition, the liver tissue showed moderate microvesicular steatosis and mild lobular activity, but there was no conclusive evidence to support SARS-CoV-2 infection or drug-induced liver injury as the cause. There were no obvious histological changes seen in heart tissue, suggesting that SARS-CoV-2 infection might not directly impair the heart. Although corticosteroid treatment is not routinely recommended to be used for SARS-CoV-2 pneumonia, 1 according to our pathological findings of pulmonary oedema and hyaline membrane formation, timely and appropriate use of corticosteroids together with ventilator support should be considered for the severe patients to prevent ARDS development. Lymphopenia is a common feature in the patients with COVID-19 and might be a critical factor associated with disease severity and mortality. 3 Our clinical and pathological findings in this severe case of COVID-19 can not only help to identify a cause of death, but also provide new insights into the pathogenesis of SARS-CoV-2-related pneumonia, which might help physicians to formulate a timely therapeutic strategy for similar severe patients and reduce mortality. This online publication has been corrected. The corrected version first appeared at thelancet.com/respiratory on February 25, 2020
                Bookmark

                Author and article information

                Journal
                Chin Med J (Engl)
                Chin. Med. J
                CM9
                Chinese Medical Journal
                Wolters Kluwer Health
                0366-6999
                2542-5641
                5 July 2020
                09 April 2020
                : 133
                : 13
                : 1595-1602
                Affiliations
                [1 ]Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing 100029, China
                [2 ]Department of Rehabilitation Medicine, China-Japan Friendship Hospital, Beijing 100029, China
                [3 ]Chinese Academy of Medical Sciences & Peking Union Medical College, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100730, China.
                Author notes
                Correspondence to: Dr. Hong-Mei Zhao, Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing 100029, China E-Mail: lucy0500@ 123456163.com ; Dr. Yu-Xiao Xie, Department of Rehabilitation Medicine, China-Japan Friendship Hospital, Beijing 100029, China E-Mail: 13501073965@ 123456163.com ; Prof. Chen Wang, Chinese Academy of Medical Sciences & Peking Union Medical College, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100730, China E-Mail: wangchen@ 123456pumc.edu.cn
                Article
                CMJ-2020-894 00011
                10.1097/CM9.0000000000000848
                7470013
                32251002
                451122c1-caf5-4505-9d3d-a47497a4b961
                Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.

                This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0

                History
                : 25 March 2020
                Categories
                Clinical Guidelines
                Custom metadata
                TRUE

                Comments

                Comment on this article